Literature DB >> 8976566

Recombinant human pigment epithelium-derived factor (PEDF): characterization of PEDF overexpressed and secreted by eukaryotic cells.

E Stratikos1, E Alberdi, P G Gettins, S P Becerra.   

Abstract

Pigment epithelium-derived factor (PEDF) is a serpin found in the interphotoreceptor matrix of the eye, which, although not a proteinase inhibitor, possesses a number of important biological properties, including promotion of neurite outgrowth and differential expression in quiescent versus senescent states of certain cell types. The low amounts present in the eye, together with the impracticality of using the eye as a source for isolation of the human protein, make it important to establish a system for overexpression of the recombinant protein for biochemical and biological studies. We describe here the expression and secretion of full-length glycosylated human recombinant PEDF at high levels (> 20 micrograms/ mL) into the growth medium of baby hamster kidney cells and characterization of the purified rPEDF by circular dichroism and fluorescence spectroscopies and neurite outgrowth assay. By these assays, the recombinant protein behaves as expected for a correctly folded full-length human PEDF. The availability of milligram amounts of PEDF has permitted quantitation of its heparin binding properties and of the effect of reactive center cleavage on the stability of PEDF towards thermal and guanidine hydrochloride denaturation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976566      PMCID: PMC2143303          DOI: 10.1002/pro.5560051220

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  26 in total

1.  Crystal structure of uncleaved ovalbumin at 1.95 A resolution.

Authors:  P E Stein; A G Leslie; J T Finch; R W Carrell
Journal:  J Mol Biol       Date:  1991-10-05       Impact factor: 5.469

2.  PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity.

Authors:  J Tombran-Tink; G G Chader; L V Johnson
Journal:  Exp Eye Res       Date:  1991-09       Impact factor: 3.467

3.  Quantitative evaluation of solution equilibrium binding interactions by affinity partitioning: application to specific and nonspecific protein-heparin interactions.

Authors:  S T Olson; P E Bock; R Sheffer
Journal:  Arch Biochem Biophys       Date:  1991-05-01       Impact factor: 4.013

4.  Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor.

Authors:  H T Wright; H X Qian; R Huber
Journal:  J Mol Biol       Date:  1990-06-05       Impact factor: 5.469

5.  Immunochemical comparison of high molecular weight angiotensinogen from amniotic fluid, plasma of men, and plasma of pregnant women.

Authors:  D A Tewksbury; E S Tryon
Journal:  Am J Hypertens       Date:  1989-05       Impact factor: 2.689

6.  Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites.

Authors:  M Bruch; V Weiss; J Engel
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Proteolytic activity directed toward pigment epithelium-derived factor in vitreous of bovine eyes. Implications of proteolytic processing.

Authors:  Y Q Wu; S P Becerra
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-09       Impact factor: 4.799

9.  Properties of thrombin- and elastase-modified human antithrombin III.

Authors:  P Gettins; B Harten
Journal:  Biochemistry       Date:  1988-05-17       Impact factor: 3.162

10.  Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta.

Authors:  A I de Agostini; S C Watkins; H S Slayter; H Youssoufian; R D Rosenberg
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

View more
  23 in total

1.  Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.

Authors:  Monika Deshpande; Luigi Notari; Preeti Subramanian; Vicente Notario; S Patricia Becerra
Journal:  Int J Oncol       Date:  2012-04-10       Impact factor: 5.650

2.  Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site.

Authors:  S Patricia Becerra; L Alberto Perez-Mediavilla; John E Weldon; Silvia Locatelli-Hoops; Preenie Senanayake; Luigi Notari; Vicente Notario; Joe G Hollyfield
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

3.  Assays for the antiangiogenic and neurotrophic serpin pigment epithelium-derived factor.

Authors:  Preeti Subramanian; Susan E Crawford; S Patricia Becerra
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

4.  Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage.

Authors:  Daniel P Fitzgerald; Preeti Subramanian; Monika Deshpande; Christian Graves; Ira Gordon; Yongzhen Qian; Yeva Snitkovsky; David J Liewehr; Seth M Steinberg; José D Paltán-Ortiz; Mary M Herman; Kevin Camphausen; Diane Palmieri; S Patricia Becerra; Patricia S Steeg
Journal:  Cancer Res       Date:  2012-01-01       Impact factor: 12.701

5.  Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor.

Authors:  M Simonovic; P G Gettins; K Volz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

6.  Pigment Epithelium-derived Factor Protects Retinal Pigment Epithelial Cells Against Cytotoxicity "In Vitro".

Authors:  Francisco M Nadal-Nicolas; S Patricia Becerra
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

7.  Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization.

Authors:  Steen V Petersen; Zuzana Valnickova; Jan J Enghild
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 8.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

9.  Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site.

Authors:  Hua Liu; Jian-Guo Ren; William L Cooper; Charles E Hawkins; Mitra R Cowan; Patrick Y Tong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

10.  Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization.

Authors:  Juan Amaral; S Patricia Becerra
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.